Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...
CEPI will work with Samsung Biologics to establish a scalable, rapid manufacturing process for recombinant-protein vaccines.
Pick two.” But a team from the University of Virginia School of Medicine has discovered a way to make vaccines that embrace ...
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the ...
With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. | The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT ...
INCHEON, South Korea, Jan. 22, 2026 /PRNewswire/ -- SK bioscience announced that it is advancing the development of a Zaire ebolavirus vaccine under a new collaboration supported by the Coalition for ...
Vaccination is one of the greatest achievements in immunology and medicine, nearly eradicating many infectious diseases that ...
The coronavirus has ground social, economic, and educational exchanges to a halt around the world. For now, public health officials are relying on tools like social distancing to minimize the harm of ...
Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...
Right now, experts say a vaccine for COVID-19 is a year or more away. But as far away as it sounds, it’s only within the ...
With a budget of up to $20m, the collaboration will establish scalable, rapid manufacturing for recombinant-protein vaccines.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results